CLGN - Company ID 0001631487
The table below shows CollPlant Biotechnologies Ltd's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|---|---|
| Revenue | $179.00K | $249.00K | $10.18M | $66.00K | $691.00K | $823.00K |
| Cost of revenue | $186.00K | $536.00K | $615.00K | $43.00K | $429.00K | $748.00K |
| Gross profit | -$7.00K | -$287.00K | $9.57M | $23.00K | $262.00K | $75.00K |
| R&D | $2.01M | $2.70M | $2.57M | $2.60M | $1.90M | $1.00M |
CollPlant Biotechnologies Ltd reported annual revenue of $2.37M for fiscal year 2025. That is up 360.4% from $515.00K in fiscal 2024. Over the 8 fiscal years shown, annual revenue declined from $5.01M (FY 2018) to $2.37M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $1.16M | $1.42M | $1.32M | $1.61M | $1.42M | $986.00K |
| Operating income | -$3.18M | -$4.41M | $5.68M | -$4.18M | -$3.06M | -$1.91M |
| Income tax | - | - | - | - | - | - |
| Net income | -$3.35M | -$4.21M | $5.76M | -$4.29M | -$3.04M | -$1.97M |
| EPS (diluted) | $0.28 | $0.37 | $0.49 | -$0.39 | -$0.30 | - |